A common use of roxithromycin is to treat chest, tonsil, skin, and genital infections.

 



  Roxithromycin is an antibiotic that is used to treat infections such as chest, tonsil, skin, and genital infections. It works by either killing or preventing the growth of bacteria (bugs). Roxithromycin, like all antibiotics, is ineffective against viral infections. Roxithromycin, also known as arrow-roxithromycin, is a semi-synthetic macrolide antibiotic that works by interfering with protein synthesis to prevent bacterial growth. The medication is prescribed to treat bacterial infections such as pharyngitis, sinusitis, bronchitis, and pneumonia, as well as urinary and soft tissue infections and otitis media.

 

Why isn't roxithromycin available in the United States?

The US Food and Drug Administration has not approved roxithromycin for marketing in the United States, but it is available in other countries. Because of the low levels of roxithromycin in breastmilk, it is unlikely to cause side effects in breastfed infants.

Is roxithromycin equivalent to amoxicillin?

Amoxicillin and roxithromycin are both equally effective in the treatment of patients with lower respiratory tract infections who require antibiotics. After 10 days of treatment with either drug, the majority of patients are still symptomatic.

 

  Roxithromycin Medical Valley is approved to treat Mycoplasma pneumoniae, Chlamydia psittaci (hornitos), and Chlamydia pneumoniae pneumonia (TW AR). Pharyngotonicillitis. Otitis media with effusion. Pneumonia is acquired socially. Infections of the skin and soft tissues (see SmPC for the full indication). It is administered orally and contains the active ingredient roxithromycin.

  Important Roxithromycin Medical Valley risks are those that necessitate special risk management activities to further investigate or mitigate the risk, allowing the medicinal product to be taken safely. Significant risks can be classified as either identified or potential.

  Concerns for which there is sufficient evidence of a link with the use of Roxithromycin Medical Valley are referred to as identified risks. Potential risks are concerns about which an association with the use of this medicine is possible based on available data, but this association has not yet been established and requires further investigation.

 

Source-

https://www.medgadget.com/2019/09/roxithromycin-market-structure-2018-with-size-value-global-players-historical-analysis-regions-segments-types-and-forecast-to-2026.html

 

Paperblog

Comments

Popular posts from this blog

Total Disc Replacement complete details Of Competitive Landscape Executive Summary Development in next decade

Dengue Vaccines development and progress towards vaccine has increased over the past few years

Non-Contact Torque Sensors Increase Fuel Economy, Improve Ride Comfort and Safety